Five-Year GSK/NeuroSearch Alliance: Big On Guarantees
Executive Summary
NeuroSearch's broad and lucrative five-year deal with GSK ties up most of the biotech's remaining un-partnered pipeline candidates. But in exchange, the Danish group secures guaranteed funding that could last it through to profitability, and a strong endorsement as to the value of its science.